1

Bibliografía

Aarsland, D.; Londos, E., y Ballard, C. (2009): “Parkinson’s disease dementia and demen-tia with Lewy bodies: different aspects of one entity”. International psychogeriatrics, 21: 216-219.

Aarsland, D., y Kurz, M. W. (2010): “The epidemiology of dementia associated with Parkinson disease”. Journal of the neurological sciences, 289: 18-22.

Acevedo, A., y Loewenstein, D. A. (2007): “Nonpharmacological cognitive interventions in aging and dementia”. Journal of geriatric Psychiatry and Neurology, 20: 239-249.

Ahlskog, J. E.; Geda, Y. E.; Graff-Radford, N.R., y Petersen, R.C. (2011): “Physical exer-cise as a preventive or disease-modifying treatment of dementia and brain aging”. Mayo clinic proceedings, 86: 876-884.

Albert, M. S. (2011): “Changes in cognition”. Neurobiology of aging, 32: S58-S63. Albert, M. S.; DeKosky, S. T.; Dickson, D.; Dubois, B.; Feldman, H. H.; Fox, N. C.;

Gamst, A.; Holtzman, D. M.; Jagust, W. J.; Petersen, R. C.; Snyder, P. J.; Carrillo, M. C.; Thies, B., y Phelps, C.H. (2011): “The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s dis-ease”. Alzheimer’s & dementia, 7: 270-279.

Amato, M. P.; Portaccio, B.; Goretti, B.; Zipoli, V.; Hakiki, B.; Giannini, M.; Pasto, L., y Razzolini, L. (2010): “Cognitive impairment in early stages of multiple sclerosis”. Neurological sciences, 31: S211-S214.

Armstrong, M. J.; Litvan, I.; Lang, A. E.; Bak, T. H.; Bhatia, K. P.; Borroni, B.; Boxer, A. L.; Dickson, D. W.; Grossman, M.; Hallett, M.; Josephs, K. A.; Kertesz, A.; Lee, S. E.; Miller, B. L.; Reich, S. G.; Riley, D. E.; Tolosa, E.; Tröster, A. I.; Vidailhet, M., y Weiner, W. J. (2013): “Criteria for the diagnosis of corticobasal degeneration”. Neu-rology, 80: 496-503.

Ash, S.; Xie, S. X.; Gross, R. G.; Dreyfuss, M.; Boller, A.; Camp, E.; Morgan, B.; O’Shea, J., y Grossman, M. (2012): “The organization and anatomy of narrative com-prehension and expression in Lewy body spectrum disorders”. Neuropsychology, 26: 368-384.

Neuropsicología de las enfermedades neurodegenerativas

2

Ballard, C.; Gauthier, S.; Corbett, A.; Brayne, C.; Aarsland, D., y Jones E. (2011a): “Alz-heimer’s disease”. Lancet Neurology, 377: 1019-1031.

Ballard, C.; Khan, Z.; Clack, H., y Corbett A. (2011b): “Nonpharmacological treatment of Alzheimer disease”. Canadian journal of Psychiatry, 56: 589-595.

Barroso, J.; Correia, R., y Nieto, A. (2011): “Neuropsicología del envejecimiento y las demencias”. En Bruna, O.; Roig, T.; Puyuelo, M.; Junqué, C., y Ruano, A., Rehabili-tación neuropsicológica. Intervención y práctica clínica. Elsevier Masson. Barcelona.

Bartrés-Faz, D., y Arenaza-Urquijo, E. M. (2011): “Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological ag-ing”. Brain topography, 24: 340-357.

Benedict, R. H. B., y Zivadinov, R. (2011): “Risk factors for and management of cogni-tive dysfunction in multiple sclerosis”. Nature reviews Neurology, 7: 332-342.

Berlucchi, G. (2011): “Brain plasticity and cognitive neurorehabilitation”. Neuropsycho-logical rehabilitation, 21: 560-578.

Black, S. E. (2011): “Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management”. Journal of the Royal College of Physicians of Edinburg, 41: 49-56.

Boeve, B. F. (2012): “Progressive supranuclear palsy”. Parkinsonism & related disorders, 18: S192-S194.

Bothe, M. R.; Uttner, I., y Brooks, M. O. (2010): “Sharpening the boundaries of Parkin-son-associated dementia: recommendation for a neuropsychological diagnostic proce-dure”. Journal of neural transmission, 117: 353-367.

Brooks, D. J. (2010): “Imaging approaches to Parkinson disease”. Journal of nuclear medicine, 51: 596-609.

Burns, A., y Iliffe, S. (2009): “Alzheimer’s disease”. British medical journal, 338: b158. Caballol, N.; Martí, M. J., y Tolosa, E. (2007): “Cognitive dysfunction and dementia in

Parkinson disease”. Movement disorders, 22: S358-S366. Cairns, N. J.; Bigio, E. H.; Mackenzie, I. R.; Neumann, M.; Lee, V. M.; Hatanpaa, K. J.;

White, C. L. 3rd.; Schneider, J. A.; Grinberg, L. T.; Halliday, G.; Duyckaerts, C.; Lowe, J. S.; Holm, I. E.; Tolnay, M.; Okamoto, K.; Yokoo, H.; Murayama, S.; Woulfe, J.; Munoz, D. G.; Dickson, D. W.; Ince, P. G.; Trojanowski, J. Q.; Mann, D. M., y Consortium for Frontotemporal Lobar Degeneration. (2007): “Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration”. Acta neuropathologica, 114: 5-22.

Calabrese, M.; Filippi, M., y Gallo, P. (2010): “Cortical lesions in multiple sclerosis”. Nature reviews Neurology, 6: 438-444.

Calabrese, P., y Penner, I. K. (2007): “Cognitive dysfunctions in multiple sclerosis – a ‘multiple disconnection syndrome’”. Journal of Neurology, 254: S18-S21.

Cerami, C.; Scarpini, E.; Cappa, S. F., y Galimberti, D. (2012): “Frontotemporal lobar degeneration: current knowledge and future challenges”. Journal of Neurology, 259: 2278-2286.

Bibliografía

3

Chiaravalloti, N. D., y DeLuca, J. (2008): “Cognitive impairment in multiple sclerosis”. Lancet Neurology, 7: 1139-1151.

Chow, T. W.; Fridhandler, J. D.; Binns M. A.; Leed, A.; Merrilees J.; Rosen, H. J.; Robin Ketelled, R., y Millerd, B. L. (2012): “Trajectories of behavioral disturbance in de-mentia”. Journal of Alzheimer’s disease, 31: 143-149.

Chui, H. C.; Victoroff, J. I.; Margolin, D.; Jagust, W.; Shankle, R., y Katzman, R. (1992): “Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers”. Neurology, 42: 473-480.

Contador, I.; Fernández-Calvo, B.; Ramos, F.; Tapias-Merino, E., y Bermejo-Pareja F. (2010): “El cribado de la demencia en atención primaria”. Revisión crítica. Revista de Neurología, 51: 677-686.

Cotelli, M.; Manenti, R., y Zanetti, O. (2012): “Reminiscence therapy in dementia: a re-view”. Maturitas, 72: 203-205.

Curlik, D. M. 2nd; Maeng, L. Y.; Agarwal, P. R., y Shors, T. J. (2013): “Physical skill training increases the number of surviving new cells in the adult hippocampus”. PLoS One, 8: e55850.

Das Nair, R.; Ferguson, H.; Stark, D. L., y Lincoln, N. B. (2012): “Memory rehabilitation for people with multiple sclerosis”. Cochrane database of systematic reviews, 14: CD008754.

Daviglus, M. L.; Plassman, B. L.; Pirzada, A.; Bell, C. C.; Bowen, P. E.; Burke, J. R.; Connolly, E. S. Jr.; Dunbar-Jacob, J. M.; Granieri, E. C.; McGarry, K.; Patel, D.; Tre-visan, M., y Williams, J. W. Jr. (2011): “Risk factors and preventive interventions for Alzheimer disease”. State of the Science. Archives of Neurology, 68: 1185-1190.

Debette, S., y Markus, H. S. (2010): “The clinical importance of white matter hyperinten-sities on brain magnetic resonance imaging: systematic review and meta-analysis”. British medical journal, 341: c3666.

Deramecourt, V.; Slade, J. Y.; Oakley, A. E.; Perry, R. H.; Ince, P. G.; Maurage, C. A., y Kalaria, R. N. (2012): “Staging and natural history of cerebrovascular pathology in dementia”. Neurology, 78: 1043-1050.

D’Haeseleer, M.; Cambron, M.; Vanopdenbosch, L., y De Keyser, J. (2011): “Vascular aspects of multiple sclerosis”. Lancet Neurology, 10: 657-666.

Drag, L. L., y Bieliauskas, L. A. (2010): “Contemporary review 2009: cognitive aging”. Journal of geriatric Psychiatry and Neurology, 23: 75-93.

Drago, V.; Babiloni, C.; Bartrés-Faz, D.; Carolia, A.; Bosch, B.; Hensch, T.; Didic, M.; Klafki, H. W.; Pievani, M.; Jovicich, J.; Venturi, L.; Spitzer, P.; Vecchio, F.; Schoenknecht, P.; Wiltfang, J.; Redolfi, A.; Forloni, G.; Blin, O.; Irving, E.; Davis, C.; Hardemark, H. G.; Giovanni, B., y Frisoni, G. B. (2011): “Disease tracking mark-ers for alzheimer’s disease at the prodromal (MCI) stage”. Journal of Alzheimer’s disease, 26: 159-199.

Emre, M.; Aarsland, D.; Brown, R.; Burn, D. J.; Duyckaerts, C.; Mizuno, Y.; Broe, G. A.; Cummings, J.; Dickson, D. W.; Gauthier, S.; Goldman, J.; Goetz, C.; Korczyn, A.; Lees, A.; Levy, R.; Litvan, I.; McKeith, I.; Olanow, W.; Poewe, W.; Quinn, N.; Sam-

Neuropsicología de las enfermedades neurodegenerativas

4

paio, C.; Tolosa, E., y Dubois, B. (2007): “Clinical diagnostic criteria for dementia associated with Parkinson’s disease”. Movement disorders, 22: 1689-1707.

Erkinjuntti, T.; Inzitari, D.; Pantoni, L.; Wallin, A.; Scheltens, P.; Rockwood, K., y Des-mond, D. W. (2000): “Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?” Annals of the New York Academy of Sciences, 903: 262-272.

Fabiani, M. (2012): “It was the best of times, it was the worst of times: A psychophysiol-ogist’s view of cognitive aging”. Psychophysiology, 49: 283-304.

Ferman, T. J., y Boeve, B. F. (2007): “Dementia with Lewy bodies”. Neurologic clinics, 25: 741-760.

Filippi, M., y Agosta, F. (2011): “Structural and functional network connectivity break-down in Alzheimer’s disease studied with magnetic resonance imaging techniques”. Journal of Alzheimer’s disease, 24: 455-474.

Filippi, M., y Roca, M. A. (2011): “MR Imaging of multiple sclerosis”. Radiology, 259: 659-681.

Freitas, S.; Simões, M. R.; Alves, L.; Duro, D., y Santana, I. (2012): “Montreal Cognitive Assessment (MoCA): Validation study for frontotemporal dementia”. Journal of ger-iatric Psychiatry and Neurology, 25: 146.

Gilman, S.; Wenning, G. K.; Low, P. A.; Brooks, D. J.; Mathias, C. J.; Trojanowski, J. Q.; Wood, N. W.; Colosimo, C.; Dürr, A.; Fowler, C. J.; Kaufmann, H.; Klockgether, T.; Lees, A.; Poewe, W.; Quinn, N.; Revesz, T.; Robertson, D.; Sandroni, P.; Seppi, K., y Vidailhet, M. (2008): “Second consensus statement on the diagnosis of multiple sys-tem atrophy”. Neurology, 71: 670-676.

Gorelick, P. B.; Scuteri, A.; Black, S. E.; Decarli, C.; Greenberg, S. M.; Iadecola, C.; Launer, L. J.; Laurent, S.; López, O. L.; Nyenhuis, D.; Petersen, R. C.; Schneider, J. A.; Tzourio, C.; Arnett, D. K.; Bennett, D. A.; Chui, H. C.; Higashida, R. T.; Lind-quist, R.; Nilsson, P. M.; Roman, G. C.; Sellke, F. W.; Seshadri, S., y American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. (2011): “Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association”. Stroke, 42: 2672-2713.

Gorno-Tempini, M. L.; Hillis, A. E.; Weintraub, S.; Kertesz, A.; Mendez, M.; Cappa, S. F.; Ogar, J. M.; Rohrer, J. D.; Black, S.; Boeve, B. F.; Manes, F.; Dronkers, N. F.; Vandenberghe, R.; Rascovsky, K.; Patterson, K.; Miller, B. L.; Knopman, D. S.; Hodges, J. R.; Mesulam, M. M., y Grossman, M. (2011): “Classification of primary progressive aphasia and its variants”. Neurology, 76:1006-1014.

Gorno-Tempini, M. L.; Dronkers, N. F.; Rankin, K. P.; Ogar, J. M.; Phengrasamy, L.; Rosen, H. J.; Johnson, J. K.; Weiner, M. W., y Miller, B. L. (2004): “Cognition and anatomy in three variants of primary progressive aphasia”. Annals of Neurology, 55: 335-346.

Bibliografía

5

Grassiot, B.; Desgranges, B.; Eustache, F., y Defer, G. (2009): “Quantification and clini-cal relevance of brain atrophy in multiple sclerosis: a review”. Journal of Neurology, 256: 1397-1412.

Green, C. S., y Bavelier, D. (2012): “Learning, attentional control, and action video games”. Current Biology, 22: R197-R206.

Hachinski, V.; Iadecola, C.; Petersen, R. C.; Breteler, M .M.; Nyenhuis, D. L.; Black, S. E.; Powers, W. J.; DeCarli, C.; Merino, J. G.; Kalaria, R. N.; Vinters, H. V.; Holtz-man, D. M.; Rosenberg, G. A.; Wallin, A.; Dichgans, M.; Marler, J. R., y Leblanc, G. G. (2006): “National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards”. Stroke, 37: 2220-2241.

Halliday, G. M.; Holton, J. L.; Revesz, T., y Dickson, D. W. (2011): “Neuropathology underlying clinical variability in patients with synucleinopathies”. Acta neuropatho-logica, 122: 187-204.

Harciarek, M., y Kertesz, A. (2011): “Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship”. Neuropsy-chology review, 21: 271-287.

Hardiman, O.; Van den Berg, L. H., y Kiernan, M. C. (2011): “Clinical diagnosis and management of amyotrophic lateral sclerosis”. Nature reviews Neurology, 7: 639-649.

Harrison, T. M.; Weintraub, S.; Mesulam, M. M., y Rogalski, E. (2012): “Superior memory and higher cortical volumes in unusually successful cognitive aging”. Jour-nal of the International Neuropsychological Society, 18: 1081-1085.

Henchcliffe, C.; Dodel, R., y Beal, M. F. (2011): “Biomarkers of Parkinson’s disease and dementia with Lewy bodies”. Progress in Neurobiology, 95: 601-613.

Herrup, K. (2010): “Reimagining Alzheimer’s disease -an age-based hypothesis”. Journal of Neuroscience, 30: 16755-16762.

Hindin, S. B., y Zelinski, E. M. (2012): “Extended practice and aerobic exercise interven-tions benefit untrained cognitive outcomes in older adults: a meta-analysis”. Journal of the American Geriatrics Society, 60: 136-141.

Hindle, J. V.; Petrelli, A.; Clare, L., y Kalbe, E. (2013): “Nonpharmacological enhance-ment of cognitive function in Parkinson’s disease: a systematic review”. Movement disorders. doi: 10.1002/mds.25377.

Hoffman, S.; Tittgemeyer, M., y Yves von Cramona, D. (2007): “Cognitive impairment in multiple sclerosis”. Current opinion in Neurology, 20: 275-280.

Hornberger, M.; Shelley, B. P.; Kipps, C. M.; Piguet, O., y Hodges, J. R. (2009): “Can progressive and non-progressive behavioural variant frontotemporal dementia be dis-tinguished at presentation?”. Journal of Neurology, Neurosurgery and Psychiatry, 80: 591-593.

Hort, J.; O’Brien, J. T.; Gainotti, G.; Pirttila, T.; Popescu, B. O.; Rektorova, I.; Sorbi, S.; Scheltens, P., y EFNS Scientist Panel on Dementia. (2010): “EFNS guidelines for the diagnosis and management of Alzheimer's disease”. European journal of Neurology, 17: 1236-1248.

Neuropsicología de las enfermedades neurodegenerativas

6

Huckans, M.; Hutson, L.; Twamley, E.; Jak, A.; Kaye, J., y Storzbach, D. (2013): “Efficacy of Cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interven-tions”. Neuropsychology review, 23: 63-80.

Hutchinson, A. D., y Mathias, J. L. (2007): “Neuropsychological deficits in frontotem-poral dementia and Alzheimer’s disease: a meta-analytic review”. Journal of Neurol-ogy, Neurosurgery and Psychiatry, 78; 917-928.

Iadecola, C. (2010): “The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia”. Acta neuropathologica, 120: 287-296.

Ismail, Z.; Nguyen, M. Q.; Fischer, C. E.; Schweizer, T. A., y Mulsant, B. H. (2012): “Neuroimaging of delusions in Alzheimer's disease”. Psychiatry research: Neuroim-aging, 202: 89-95.

Jack, C. R. Jr. (2011): “Alliance for Aging Research AD Biomarkers Work Group: struc-tural MRI”. Neurobiology of aging, 32: S48-S57.

Jack, C. R. Jr. (2012): “Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play”. Radiology, 263: 344-361.

Jack, C. R.; Knopman, D. S.; Weigand, S. D.; Wiste, H. J.; Vemuri, P.; Lowe, V.; Kant-arci, K.; Gunter, J. L.; Senjem, M. L.; Ivnik, R. J.; Roberts, R. O.; Rocca, W. A.; Boeve, B. F., y Petersen, R. C. (2012): “An operational approach to National Institute on Aging-Alzheimer’s Association criteria for preclinical Alzheimer disease”. Annals of Neurology, 71: 765-775.

Jones, N. (2011): “Movement disorders: Imaging differentiates progressive supranuclear palsy from Parkinson disease”. Nature reviews Neurology, 7: 186.

Joubert, S.; Brambati, S. M.; Ansado, J.; Barbeau, E. J.; Felician, O.; Didic, M.; Lacombe, J.; Goldstein, R.; Chayer, C., y Kergoat, M. . (2010): “The cognitive and neural ex-pression of semantic memory impairment in mild cognitive impairment and early Alzheimer’s disease”. Neuropsychologia, 48: 978-988.

Junqué, C., y Jurado M. A. (2009). “Envejecimiento, demencias y otros procesos degener-ativos”. En Junqué, C., y Barroso, J., Manual de neuropsicología. Síntesis. Madrid.

Kalaria, R. N.; Kenny, R. A.; Ballard, C. G.; Perry, R.; Ince, P., y Polvikoski, T. (2004): “Towards defining the neuropathological substrates of vascular dementia”. Journal of neurological sciences, 226: 75-80.

Kaufer, D. I., y Tröster, A. I. (2008): “Neuropsychology of dementia with Lewy bodies”. Handbook of clinical Neurology, 88: 549-566.

Kawai, Y.; Suenaga, M.; Watanabe, H., y Sobue, G. (2009): “Cognitive impairment in spinocerebellar degeneration”. European Neurology, 61: 257-268.

Kehagia, A. A.; Barker, R. A., y Robbins, T. W. (2010): “Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s dis-ease”. Lancet Neurology, 9: 1200-1213.

Kertesz, A.; Jesso, S.; Harciarek, M.; Blair, M., y McMonagle, P. (2010): “What is se-mantic dementia? A cohort study of diagnostic features and clinical boundaries”. Ar-chives of Neurology, 67: 483-489.

Bibliografía

7

Kiernan, M. C.; Vucic, S.; Cheah, B. C.; Turner, M. R.; Eisen, A.; Hardiman, O.; Burrell, J. R., y Zoing, M. C. (2011): “Amyotrophic lateral sclerosis”. Lancet, 377: 942-955.

Knöchel, C.; Oertel-Knöchel, V.; O’Dwyer, L.; Prvulovic, D.; Alves, G.; Kollmann, B., y Hampel, H. (2012): “Cognitive and behavioural effects of physical exercise in psy-chiatric patients”. Progress in Neurobiology, 96: 46-68.

Kövari, E.; Horvath, J., y Bouras, C. (2009): “Neuropathology of Lewy body disorders”. Brain research bulletin, 80: 203-210.

Kraft, E. (2012): “Cognitive function, physical activity, and aging: possible biological links and implications for multimodal interventions”. Neuropsychology, development, and cognition. Section B, aging Neuropsychology and cognition, 19: 248-263.

Kril, J. J., y Halliday, G. M. (2011): “Pathological staging of frontotemporal lobar degen-eration”. Journal of molecular Neuroscience, 45: 379-383.

Kueider, A. M.; Parisi, J. M.; Gross, A. L., y Rebok, G. W. (2012): “Computerized cogni-tive training with older adults: a systematic review”. PLoS One, 7: e40588.

Kurz, A.; Thöne-Otto, A.; Cramer, B.; Egert, S.; Frölich, L.; Gertz, H. J.; Kehl, V.; Wagenpfeil, S., y Werheid, K. (2012): “CORDIAL: cognitive rehabilitation and cog-nitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial”. Alzheimer disease and associated disorders, 26: 246-253.

Lambert, J. C., y Amouyel, P. (2011): “Genetics of Alzheimer’s disease: new evidences for an old hypothesis?”. Current opinion in Genetics & development, 21: 295-301.

Lambrecq, V.; Langbour, N.; Guehl, D.; Bioulac, B.; Burbaud, P., y Rotge, J. Y. (2013): “Evolution of brain gray matter loss in Huntington's disease: a meta-analysis”. Euro-pean journal of Neurology, 20: 315-321.

Leverenz, J. B.; Quinn, J. F.; Zabetian, C.; Zhang, J.; Montine, K. S., y Montine, T. J. (2009): “Cognitive impairment and dementia in patients with Parkinson disease”. Current topics in medicinal chemistry, 9: 903-912.

Leyton, C. E.; Villemagne, V. L.; Savage, S.; Pike, K. E.; Ballard, K. J.; Piguet, O.; Bur-rell, J. R.; Rowe, C. C., y Hodges. J. R. (2011): “Subtypes of progressive aphasia: ap-plication of the international consensus criteria and validation using b-amyloid imag-ing”. Brain, 134: 3030-3043.

Li, H.; Li, J.; Li, N.; Li, B.; Wang, P., y Zhou, T. (2011): “Cognitive intervention for persons with mild cognitive impairment: A meta-analysis”. Ageing research reviews, 10: 285-296.

Lindesay, J.; Bullock, R.; Daniels, H.; Emre, M.; Förstl, H.; Frölich, L.; Gabryelewicz, T.; Martínez-Lage, P.; Monsch, A. U.; Tsolaki, M., y Van Laar, T. (2010): “Turning principles into practice in Alzheimer’s disease”. International journal of clinical practice, 64: 1198-1209.

Litvan, I.; Goldman, J. G.; Tröster, A. I.; Schmand, B. A.; Weintraub, D.; Petersen, R. C.; Mollenhauer, B.; Adler, C. H.; Marder, K.; Williams-Gray, C. H.; Aarsland, D.; Kulisevsky, J.; Rodríguez-Oroz, M. C.; Burn, D. J.; Barker, R. A., y Emre, M. (2012): “Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society task force guidelines”. Movement disorders, 27: 349-356.

Neuropsicología de las enfermedades neurodegenerativas

8

Lustig, C.; Shah, P.; Seidler, R., y Reuter-Lorenz, P. A. (2009): “Aging, training, and the brain: a review and future directions”. Neuropsychology review, 19: 504-522.

Mandal, P. K.; Joshi, J., y Saharan S. (2012): “Visuospatial perception: an emerging bi-omarker for Alzheimer’s disease”. Journal of Alzheimer’s disease, 31: S117-S135.

Masdeu, J. C.; Kreisl, W. C., y Berman, K. F. (2012): “The neurobiology of Alzheimer disease defined by neuroimaging”. Current opinion in Neurology, 25: 410-420.

Mather, M. (2012): “The emotion paradox in the aging brain”. Annals of the New York Academy of Sciences, 1251: 33-49.

Mathias, J. L., y Burke, J. (2009): “Cognitive functioning in Alzheimer’s and vascular dementia: a meta-analysis”. Neuropsychology, 23: 411-423.

Mayeux, R. (2010): “Early Alzheimer’s disease”. New England journal of Medicine, 362: 2194-2201.

McKeith, I. (2007): “Dementia with Lewy bodies”. Handbook of clinical Neurology, 84: 531-548.

McKeith, I. G.; Dickson, D. W.; Lowe, J.; Emre, M.; O’Brien, J. T.; Feldman, H.; Cum-mings, J.; Duda, J. E.; Lippa, C.; Perry, E. K.; Aarsland, D.; Arai, H.; Ballard, C. G.; Boeve, B.; Burn, D. J.; Costa, D.; Del Ser, T.; Dubois, B.; Galasko, D.; Gauthier, S.; Goetz, C. G.; Gómez-Tortosa, E.; Halliday, G.; Hansen, L. A.; Hardy, J.; Iwatsubo, T.; Kalaria, R. N.; Kaufer, D.; Kenny, R. A.; Korczyn, A.; Kosaka, K.; Lee, V. M.; Lees, A.; Litvan, I.; Londos, E.; López, O. L.; Minoshima, S.; Mizuno, Y.; Molina, J. A.; Mukaetova-Ladinska, E. B.; Pasquier, F.; Perry, R. H.; Schulz, J. B.; Trojanowski, J. Q.; Yamada, M., y Consortium on DLB. (2005): “Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium”. Neurology, 65: 1863-1872.

McKhann, G. M; Knopman, D. S.; Chertkowe, H.; Hyman, B. T.; Jack, C. R. Jr.; Kawash, C. H.; Klunk, W. E.; Koroshetz, W. J.; Manly, J. J.; Mayeux, R.; Mohs, R. C.; Morris, J. C.; Rossor, M. N.; Scheltens, P.; Carrillo, M. C.; Thies, B.; Weintraub, S., y Phelps, C. H. (2011): “The diagnosis of dementia due to Alzheimer’s disease: Recommenda-tions from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease”. Alzheimer’s & dementia, 7: 263-269.

Mendez, M. F.; Joshi, A.; Tassniyom, K.; Teng, E., y Shapira, J. S. (2013): “Clinicopatho-logic differences among patients with behavioral variant frontotemporal dementia”. Neurology, 80: 561-568.

Merino, J. G., y Hachinski, V. (2009): “Implications and conclusions-vascular cognitive impairment: evolution of the concept”. Journal of the International Neuropsychologi-cal Society, 15: 924-926.

Metzler-Baddeley, C. (2007): “A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson’s disease with de-mentia”. Cortex, 43: 583-600.

Miller, R. G.; Jackson, C. E.; Kasarskis, E. J.; England, J. D.; Forshew, D.; Johnston, W.; Kalra, S.; Katz, J. S.; Mitsumoto, H.; Rosenfeld, J.; Shoesmith, C.; Strong, M. J.; Woolley, S. C., y Quality Standards Subcommittee of the American Academy of Neurology. (2009): “Practice parameter update: the care of the patient with amyo-

Bibliografía

9

trophic lateral sclerosis: multidisciplinary care, symptom management, and cogni-tive/behavioral impairment (an evidence-based review): report of the Quality Stand-ards Subcommittee of the American Academy of Neurology”. Neurology, 73: 1227-1233.

Morelli, M.; Arabia, G.; Novellino, F.; Salsone, M.; Giofrè, L.; Condino, F.; Messina, D., y Quattrone, A. (2011): “MRI measurements predict PSP in unclassifiable parkinson-isms: a cohort study”. Neurology, 77: 1042-1047.

Morley, J. F., y Hurtig, H. I. (2010): “Current understanding and management of Parkin-son disease: Five new things Neurology”. Neurology, 75: S9-S15.

Nelson, P. T.; Alafuzoff, I.; Bigio, E. H.; Bouras, C.; Braak, H.; Cairns, N. J.; Castellani, R. J.; Crain, B. J.; Davies, P.; Del Tredici, K.; Duyckaerts, C.; Frosch, M. P.; Haroutunian, V.; Hof, P. R.; Hulette, C. M.; Hyman, B. T.; Iwatsubo, T.; Jellinger, K. A.; Jicha, G. A.; Kövari, E.; Kukull, W. A.; Leverenz, J. B.; Love, S.; Mackenzie, I. R.; Mann, D. M.; Masliah, E.; McKee, A. C.; Montine, T .J.; Morris, J. C.; Schneider, J. A.; Sonnen, J. A.; Thal, D. R.; Trojanowski, J. Q.; Troncoso, J. C.; Wisniewski, T.; Woltjer, R. L., y Beach, T. G. (2012): “Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature”. Journal of Neuropathology & experimental Neurology, 71: 362-381.

O'Brien, J. T.; Erkinjuntti, T.; Reisberg, B.; Roman, G.; Sawada, T.; Pantoni, L.; Bowler, J. V.; Ballard, C.; DeCarli, C.; Gorelick, P. B.; Rockwood, K.; Burns, A.; Gauthier, S., y DeKosky, S. T. (2003): “Vascular cognitive impairment”. Lancet Neurology, 2: 89-98.

Olazarán-Rodríguez, J.; Agüera-Ortiz, L. F.; Muñiz-Schwochert, R. (2012): “Síntomas psicológicos y conductuales de la demencia: prevención, diagnóstico y tratamiento”. Revista de Neurología, 55: 598-608.

Olazarán, J.; Reisberg, B.; Clare, L.; Cruz, I.; Peña-Casanova, J.; Del Ser, T.; Woods, B.; Beck, C.; Auer, S.; Lai, C.; Spector, A.; Fazio, S.; Bond, J.; Kivipelto, M.; Brodaty, H.; Rojo, J. M.; Collins, H.; Teri, L.; Mittelman, M.; Orrell, M.; Feldman, H. H., y Muñiz, R. (2010): “Nonpharmacological therapies in Alzheimer’s disease: a system-atic review of efficacy”. Dementia and geriatric cognitive disorders, 30: 161-178.

Onyike, C. U. (2011): “What is the life expectancy in frontotemporal lobar degeneration?” Neuroepidemiology, 37: 166-167.

Papathanasiou, N. D.; Boutsiadis, A.; Dickson, J., y Bomanji, J. B. (2012): “Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies”. Parkinsonism & related disorders, 18: 225-229.

Paulsen, J. S. (2009): “Functional imaging in Huntington’s disease”. Experimental Neu-rology, 216: 272-277.

Paulsen, J. S. (2011): “Cognitive impairment in Huntington disease: diagnosis and treat-ment”. Current Neurology and Neuroscience reports, 11: 474-483.

Pendlebury, S. T., y Rothwell, P. M. (2009): “Prevalence, incidence, and factors associat-ed with pre-stroke and post-stroke dementia: a systematic review and meta-analysis”. Lancet Neurology, 8: 1006-1018.

Neuropsicología de las enfermedades neurodegenerativas

10

Petersen, R. C. (2007): “Mild cognitive impairment: current research and clinical implica-tions”. Seminars in Neurology, 27: 22-31.

Petersen, R. C. (2011): “Mild Cognitive Impairment”. New England journal of Medicine; 364: 2227-2234.

Pievani, M.; de Haan, W.; Wu, T.; Seeley, W. W., y Frisoni, G. B. (2011): “Functional network disruption in the degenerative dementias”. Lancet Neurology, 10: 829-843.

Piguet, O.; Hornberger, M.; Mioshi, E., y Hodges, J. R. (2011): “Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management”. Lancet Neu-rology, 10: 162-72.

Popp, J., y Arlt, S. (2011): “Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer’s disease”. Current opinion in Psychiatry, 24: 556-561.

Ramagopalan, S. V.; Dobson, R.; Meier, U. C., y Giovannoni, G. (2010): “Multiple scle-rosis: risk factors, prodromes, and potential causal pathways”. Lancet Neurology, 9: 727-739.

Rami, L.; Valls-Pedret, C.; Bartrés-Faz, D.; Caprile, C.; Solé-Padullés, C.; Castellví, M.; Olives, J.; Bosch, B., y Molinuevo, J. L. (2011): “Cuestionario de reserva cognitiva. Valores obtenidos en población anciana sana y con enfermedad de Alzheimer”. Re-vista de Neurología, 52: 195-201.

Rascovsky, K.; Hodges, J. R., Knopman, D.; Mendez, M. F.; Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H.; Dopper, E. G.; Onyike, C. U., Hillis, A. E.; Josephs, K. A., Boeve, B. F.; Kertesz, A., Seeley, W. W.; Rankin, K. P., Johnson, J. K.; Gor-no-Tempini, M. L.; Rosen, H.; Prioleau-Latham, C. E.; Lee, A.; Kipps, C. M.; Lillo, P.; Piguet, O.; Rohrer, J. D.; Rossor, M. N.; Warren, J. D.; Fox, N. C.; Galasko, D.; Salmon, D. P.; Black, S. E.; Mesulam, M.; Weintraub, S.; Dickerson, B. C.; Diehl-Schmid, J.; Pasquier, F.; Deramecourt, V.; Lebert, F.; Pijnenburg, Y.; Chow, T. W.; Manes, F.; Grafman, J.; Cappa, S. F.; Freedman, M.; Grossman, M., y Miller, B. L. (2011): “Sensitivity of revised diagnostic criteria for the behavioural variant of fron-totemporal dementia”. Brain, 134: 2456-2477.

Rascovsky, K.; Hodges, J. R.; Kipps, C. M.; Johnson, J. K; Seeley, W. W.; Mendez, M. F.; Knopman, D.; Kertesz, A.; Mesulam, M.; Salmon, D. P.; Galasko, D.; Chow, T. W.; Decarli, C.; Hillis, A.; Josephs, K.; Kramer, J. H.; Weintraub, S.; Grossman, M.; Gorno-Tempini, M. L., y Miller, B. M. (2007): “Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future direc-tions”. Alzheimer disease and associated disorders, 21: S14-S18.

Redjak, K.; Jackson, S., y Giovannoni, G. (2010): “Multiple sclerosis: a practical over-view for clinicians”. British medical bulletin, 95: 79-104.

Reijnders, J.; Van Heugten, C., y Van Boxtel, M. (2013): “Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic re-view”. Ageing research reviews, 12: 263-275.

Respondek, G.; Roeber, S.; Kretzschmar, H.; Troakes, C.; Al-Sarraj, S.; Gelpi, E.; Gaig, C.; Chiu, W. Z.; Van Swieten, J. C.; Oertel, W. H., y Höglinger, G. U. (2013): “Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkin-

Bibliografía

11

son plus syndromes criteria for the diagnosis of progressive supranuclear palsy”. Movement disorders, 28: 504-509.

Reynolds, R.; Roncaroli, F.; Nicholas, R.; Radotra, B.; Gveric, D., y Howell, O. (2011): “The neuropathological basis of clinical progression in multiple sclerosis”. Acta neu-ropathologica, 122: 155-170.

Robins-Wahlin, T. B., y Byrne, G. J. (2011): “Personality changes in Alzheimer’s disease: a systematic Review”. International journal of geriatric Psychiatry, 26: 1019-1029.

Rohrer, J. D. (2011): “Behavioural variant frontotemporal dementia-defining genetic and pathological subtypes”. Journal of molecular Neuroscience, 45: 583-588.

Román, G. C.; Tatemichi, T. K.; Erkinjuntti, T.; Cummings, J. L.; Masdeu, J. C.; García, J. H.; Amaducci, L.; Orgogozo, J. M.; Brun, A.; Hofman, A.; Moody, D. M.; O’Brien, M. D.; Yamaguchi, T.; Grafman, J.; Drayer, B. P.; Bennett, D. A.; Fisher, M.; Ogata, J.; Kokmen, E.; Berejo, F.; Wolf, P. A.; Gorelick, P. B.; Bick, K. L.; Pajeau, A. K.; Bell, M. A.; DeCarli, C.; Culebras, A.; Korczyn, A. D.; Bogousslavsky, J.; Hartmenn, A., y Scheinberg, P. (1993): “Vascular dementia: diagnostic criteria for research stud-ies. Report of the NINDS-AIREN International Workshop”. Neurology, 43: 250-260.

Romanowski, C. A. J., y Wilkinson, I. D. (2011): “Atrophy: When too much atrophy is too little brain”. Neuroradiology, 53: S133-S139.

Roos, R. A. (2010): “Huntington’s disease: a clinical review”. Orphanet journal of rare diseases, 5: 40.

Rosenberg, G. A. (2009): “Inflammation and white matter damage in vascular cognitive impairment”. Stroke, 40: S20-23.

Ross, C. A., y Tabrizi, S. J. (2011): “Huntington’s disease: from molecular pathogenesis to clinical treatment”. Lancet Neurology, 10: 83-98.

Rosti-Otajärvi, E. M., y Hämäläinen, P. I. (2011): “Neuropsychological rehabilitation for multiple sclerosis”. Cochrane database of systematic reviews, 9: CD009131.

Sahathevan, R.; Brodtmann, A., y Donnan, G. A. (2012): “Dementia, stroke, and vascular risk factors; a review”. International journal of stroke, 7: 61-73.

Salmon, D. P., y Filoteo, J. V. (2007): “Neuropsychology of cortical versus subcortical dementia syndromes”. Seminars in Neurology, 27: 7-21.

Sauvaget, F., y Litvan, I. (2012): “Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy”. Movement disorders, 27: 1711-1713.

Savva, G. M.; Stephan, B. C. y Alzheimer’s Society Vascular Dementia Systematic Re-view Group. (2010): “Epidemiological studies of the effect of stroke on incident de-mentia: a systematic review”. Stroke, 41: e41-46.

Schmidt, C.; Wolff, M.; Weitz, M.; Bartlau, T.; Korth, C., y Zerr, I (2011): “Rapidly pro-gressive alzheimer disease”. Archives of Neurology, 68: 1124-1130.

Seelaar, H.; Rohrer, J. D.; Pijnenburg, Y. A.; Fox, N. C., y Van Swieten, J. C. (2011): “Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a re-view”. Journal of Neurology, Neurosurgery and Psychiatry, 82: 476-486.

Seeley, W. W.; Zhou, J., y Kim, E. J. (2012): “Frontotemporal dementia: what can the behavioral variant teach us about human brain organization?” Neuroscientist, 18: 373.

Neuropsicología de las enfermedades neurodegenerativas

12

Selnes, O. A., y Vinters, H. V. (2006): “Vascular cognitive impairment”. Nature clinical practice Neurology, 2: 538-547.

Shany-Ur, T., y Rankin, K. P. (2011): “Personality and social cognition in neurodegenera-tive disease”. Current opinion in Neurology, 24: 550-555.

Shoulson, I., y Young, A. B. (2011): “Milestones in Huntington disease”. Movement dis-orders, 26: 1127-1133.

Sinha, N.; Firbank, M., y O’Brien, J. (2012): “Biomarkers in dementia with Lewy bodies: a review”. International journal of geriatric Psychiatry, 27: 443-453.

Siri, C.; Duerr, S.; Canesi, M.; Delazer, M.; Esselink, R.; Bloem, B. R.; Gurevich, T.; Balas, M.; Giladi, N.; Santacruz, P.; Marti, F.; Tolosa, E.; Rubino, A.; Meco, G.; Poewe, W.; Pezzoli, G.; Wenning, G., y Antonini, A. (2013): “A cross-sectional mul-ticenter study of cognitive and behavioural features in multiple system atro-phy patients of the parkinsonian and cerebellar type”. Journal of neural transmission, 120: 613-618.

Smith, E. E.; Schneider, J. A.; Wardlaw, J. M., y Greenberg, S. M. (2012): “Cerebral microinfarcts: the invisible lesions”. Lancet Neurology, 11: 272-282.

Snowden, M.; Steinman, L.; Mochan, K.; Grodstein, F.; Prohaska, T. R.; Thurman, D. J.; Brown, D. R.; Laditka, J. N.; Soares, J.; Zweiback, D. J.; Little, D., y Anderson, L. A. (2011): “Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research”. Journal of the American Geriatrics Society, 59: 704-716.

Sorbi, S.; Hort, J.; Erkinjuntti, T.; Fladby, T.; Gainotti, G.; Gurvit, H.; Nacmias, B.; Pas-quier, F.; Popescu, B. O.; Rektorova, I.; Religa, D.; Rusina, R.; Rossor, M.; Schmidt, R.; Stefanova, E.; Warren, J. D; Scheltens, P., y EFNS Scientist Panel on Dementia and Cognitive Neurology. (2012): “EFNS-ENS Guidelines on the diagnosis and man-agement of disorders associated with dementia”. European journal of Neurology, 19: 1159-1179.

Sperling, R. A.; Aisen, P. S.; Beckett, L. A.; Bennett, D. A.; Craft, S.; Fagan, A. M.; Iwatsubo, T.; Jack, C. R.; Kaye, J.; Montine, T. J.; Park, D. C.; Reiman, E. M.; Rowe, C. C.; Siemers, E.; Stern, Y.; Yaffe, K.; Carrillo, M. C.; Thies, B.; Morrison-Bogorad, M.; Wagster, M. V., y Phelps, C. H. (2011): “Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s dis-ease”. Alzheimer’s & Dementia, 7: 280-292.

Stephan, B. C.; Matthews, F. E.; Khaw, K. T.; Dufouil, C., y Brayne, C. (2009): “Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)”. Alzheimer’s research & therapy, 1: 4.

Thal, D. R.; Grinberg, L. T., y Attems, J. (2012): “Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain”. Ex-perimental Gerontology, 47: 816-824.

Torralva, T.; Roca, M.; Gleichgerrcht, E.; Bonifacio, A.; Raimondi, C., y Manes, F. (2011): “Validation of the spanish version of the Addenbrooke’s cognitive examina-tion revised (ACE-R)”. Neurología, 26: 351-356.

Bibliografía

13

Tröster, A. I. (2008): “Neuropsychological characteristics of dementia with Lewy bodies and Parkinson’s disease with dementia: differentiation, early detection, and implica-tions for ‘mild cognitive impairment’ and biomarkers”. Neuropsychology review, 18: 103-119.

Tsermentseli, S.; Leigh, P. N., y Goldstein, L. H. (2012): “The anatomy of cognitive im-pairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction”. Cor-tex, 48: 166-182.

Valenzuela, M. J., y Sachdev P. (2006). Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ). Psycho-logical Medicine, 7: 1015-1025.

Wang, S.; Melhem, E. R.; Poptani, H., y Woo, J. H. (2011): “Neuroimaging in amyotrophic lateral sclerosis”. Neurotherapeutics, 8: 63-71.

Watson, R.; Blamire, A. M.; Colloby, S. J.; Wood, J. S.; Barber, R.; He, J., y O’Brien, J. T. (2012): “Characterizing dementia with Lewy bodies by means of diffusion tensor imaging”. Neurology, 79: 906-914.

Weintraub, S.; Salmon, D.; Mercaldo, N.; Ferris, S.; Graff-Radford, N. R.; Chui, H.; Cummings, J.; DeCarli, C.; Foster, N. L.; Galasko, D.; Peskind, E.; Dietrich, W.; Beekly, D. L.; Kukull, W. A., y Morris, J. C. (2009): “The Alzheimer’s Disease Cen-ters’ Uniform Data Set (UDS): the neuropsychologic test battery”. Alzheimer disease and associated disorders, 23: 91-101.

Wenning, G. K., y Stefanova, N. (2009): “Recent developments in multiple system atro-phy”. Journal of Neurology, 256: 1791-1808.

Wenning, G. K.; Geser, F.; Krismer, F.; Seppi, K.; Duerr, S.; Boesch, S.; Köllensperger, M.; Goebel, G.; Pfeiffer, K. P.; Barone, P.; Pellecchia, M. T.; Quinn, N. P.; Kou-kouni, V.; Fowler, C. J.; Schrag, A.; Mathias, C. J.; Giladi, N.; Gurevich, T.; Dupont, E.; Ostergaard, K.; Nilsson, C. F.; Widner, H.; Oertel, W.; Eggert, K. M.; Albanese, A.; Del Sorbo, F.; Tolosa, E.; Cardozo, A.; Deuschl, G.; Hellriegel, H.; Klockgether, T.; Dodel, R.; Sampaio, C.; Coelho, M.; Djaldetti, R.; Melamed, E.; Gasser, T.; Kamm, C.; Meco, G.; Colosimo, C.; Rascol, O.; Meissner, W. G.; Tison, F.; Poewe, W., y European Multiple System Atrophy Study Group. (2013): “The natural history of multiple system atrophy: a prospective European cohort study”. Lancet Neurology, 12: 264-274.

Wenning, G. K.; Litvan, I., y Tolosa, E. (2011): “Milestones in atypical and secondary Parkinsonisms”. Movement Disorders, 26: 1083-1095.

Whitwell, J. L.; Xu, J.; Mandrekar, J.; Boeve, B. F.; Knopman, D. S.; Parisi, J. E.; Sen-jem, M. L.; Dickson, D. W.; Petersen, R. C.; Rademakers, R.; Jack, C. R. Jr., y Jo-sephs, K. A. (2013): “Frontal asymmetry in behavioral variant frontotemporal demen-tia: clinicoimaging and pathogenetic correlates”. Neurobiology of aging, 34: 636-639.

Williams, D. R., y Lees, A. J. (2009): “Progressive supranuclear palsy: clinicopathologi-cal concepts and diagnostic challenges”. Lancet Neurology, 8: 270-279.

Williams, J. W.; Plassman, B. L.; Burke, J., y Benjamin, S. (2010): “Preventing Alz-heimer’s disease and cognitive decline”. Evidence report/technology assessment, 193: 1-727.

Neuropsicología de las enfermedades neurodegenerativas

14

Wolk, D. A.; Dickerson, B. C., y Alzheimer’s Disease Neuroimaging Initiative. (2011): “Fractionating verbal episodic memory in Alzheimer’s disease”. Neuroimage, 54: 1530-1539.

Yaffe, K.; Fiocco, A. J.; Lindquist, K.; Vittinghoff, E.; Simonsick, E. M.; Newman, A. B.; Satterfield, S.; Rosano, C.; Rubin, S. M.; Ayonayon, H. N., y Barris, T. B. (2009): “Predictors of maintaining cognitive function in older adults. The Health ABC Study”. Neurology, 72: 2029-2035.

Yang, S.; Sajatovic, M., y Walter, B. L. (2012): “Psychosocial interventions for depres-sion and anxiety in Parkinson’s disease”. Journal of geriatric Psychiatry and Neurol-ogy, 25: 113-121.

Zahodne, L. B.; Glymour, M. M.; Sparks, C.; Bontempo, D.; Dixon, R. A; MacDonald, S. W. S., y Manly, J. J. (2011): “Education does not slow cognitive decline with aging: 12-Year Evidence from the Victoria Longitudinal Study”. Journal of the International Neuropsychological Society, 17: 1039-1046.

Zald, D. H., y Andreotti, C. (2010): “Neuropsychological assessment of the orbital and ventromedial prefrontal cortex”. Neuropsychologia, 48: 3377-3391.

Zhou, A., y Jia, J. (2009): “Different cognitive profiles between mild cognitive impair-ment due to cerebral small vessel disease and mild cognitive impairment of Alz-heimer’s disease origin”. Journal of the International Neuropsychological Society, 15: 898-905.